Inventor profile of:

Ivan E. Danhof

City:

Grand Prairie, Texas

Country:

United States

Published Applications:

14

Last publication date:

2019-08-22

Top Assignees for applications by Ivan E. Danhof

The entities that hold a legal rights for patent applications filed by inventor Danhof Ivan E.:

Recent patent applications by Danhof Ivan E.

Ivan E. Danhof from Grand Prairie, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-08-22
US20190255095A1
Human necessities

Compositions and methods of aloe polysaccharides

#2 | 2019-05-16
US20190142825A1
Human necessities

Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury

#3 | 2018-02-01
US20180028530A1
Human necessities

Role of N-2-hydroxy-ethyl-piperazine-N′-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury

#4 | 2017-11-23
US20170333513A1
Human necessities

Decubitus treatment system

#5 | 2017-08-31
US20170246199A1
Human necessities

Compositions and methods of Aloe polysaccharides

#6 | 2015-05-21
US20150140138A1
Human necessities

Decubitus treatment system

#7 | 2014-12-25
US20140378467A1
Human necessities

Role of N-2-hydroxy-ethyl-piperazine-N′-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury

#8 | 2014-04-03
US20140093593A1
Human necessities

Decubitus treatment system

#9 | 2014-02-27
US20140057867A1
Human necessities

Compositions and methods of aloe polysaccharides

#10 | 2012-12-20
US20120322757A1
Human necessities

Methods for Aloe Processing

#11 | 2012-01-26
US20120022018A1
Human necessities

ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT

#12 | 2011-12-08
US20110300227A1
Human necessities

MALIGNANT NEOPLASM TREATMENT PROTOCOL

#13 | 2011-07-14
US20110172181A1
Human necessities

Compositions and methods of aloe polysaccharides

#14 | 2011-03-24
US20110071157A1
Human necessities

Role of N-2-hydroxy-ethyl-piperazine-N′-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury

InventorID:

666992 āŽ˜